NPs Basic Information

Name
Deisopropylatrazine
Molecular Formula C5H8ClN5
IUPAC Name*
6-chloro-2-N-ethyl-1,3,5-triazine-2,4-diamine
SMILES
CCNC1=NC(=NC(=N1)N)Cl
InChI
InChI=1S/C5H8ClN5/c1-2-8-5-10-3(6)9-4(7)11-5/h2H2,1H3,(H3,7,8,9,10,11)
InChIKey
IVENSCMCQBJAKW-UHFFFAOYSA-N
Synonyms
Deisopropylatrazine; Atrazine-desisopropyl; 1007-28-9; Desisopropyl Atrazine; 6-Deisopropylatrazine; desisopropylatrazine; deethylsimazine; Desethylsimazine; 6-Chloro-N2-ethyl-1,3,5-triazine-2,4-diamine; s-Triazine, 2-amino-4-chloro-6-(ethylamino)-; G 28279; 2-Amino-4-chloro-6-ethylamino-s-triazine; 2-Chloro-4-amino-6-ethylamino-s-triazine; 2-amino-4-chloro-6-(ethylamino)-s-triazine; Atrazin-desisopropyl; 1,3,5-Triazine-2,4-diamine, 6-chloro-N-ethyl-; 6-Chloro-N-ethyl-1,3,5-triazine-2,4-diamine; G-28279; 6-chloro-2-N-ethyl-1,3,5-triazine-2,4-diamine; Amino-2-chloro-6-ethylamino-s-triazine; E8EGZ3S34H; 2-Choro-6-ethylamino-4-amino-s-triazine; CHEBI:27399; NSC-13909; Atrazine Desisopropyl 100 microg/mL in Methanol; Atrazine-desisopropyl 10 microg/mL in Acetonitrile; Atrazine-desisopropyl 100 microg/mL in Acetonitrile; Caswell No. 033F; 2-CEAT; NSC 13909; CCRIS 3557; Atrazine-desisopropyl D5 (ethylamino D5); 6-chloro-4-N-ethyl-1,3,5-triazine-2,4-diamine; UNII-E8EGZ3S34H; Desethyl simazine; F 703; 6-Chloro-N-ethyl-1,3,5-triazine-2,4-diamine (Atrazine-desisopropyl); Atrazine-desisopropyl D5 (ethylamino D5) 100 microg/mL in Acetone; ATRAZIN-DESISOPROPYL PESTANA; Simazine, desethyl; Atrazine deisopropyl; CEAT; Atrazine, desisopropyl; Desisopropylatrazine-d5; starbld0009527; 2-chloro-4-(ethylamino)-6-amino-s-triazine; DEISOPROPYL ATRAZINE; DSSTox_CID_17495; DSSTox_RID_79323; DSSTox_GSID_37495; SCHEMBL1425806; CHEMBL1895845; DTXSID0037495; Desisopropylatrazine-d5(ethyl-d5); ZINC896276; NSC13909; Tox21_300753; AKOS006228875; NCGC00163766-01; NCGC00163766-02; NCGC00163766-03; NCGC00163766-04; NCGC00254658-01; Atrazine-desisopropyl, analytical standard; 2-chloro-4-ethylamino-6-amino-s-triazine; CAS-1007-28-9; CS-0439692; F-703; FT-0666031; C06556; 1,5-Triazine-2,4-diamine, 6-chloro-N-ethyl-; J-000205; Q22330219; 3-AMINO-3-(3,5-DICHLORO-PHENYL)-PROPIONICACID; Atrazine-desisopropyl, PESTANAL(R), analytical standard; 1,3,5-TRIAZINE-2,4-DIAMINE, 6-CHLORO-N2-ETHYL-
CAS 1007-28-9
PubChem CID 13878
ChEMBL ID CHEMBL1895845
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organoheterocyclic compou
      • Class: Triazines
        • Subclass: Aminotriazines
          • Direct Parent: 1,3,5-triazine-2,4-diamin

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 173.6 ALogp: 1.1
HBD: 2 HBA: 5
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 76.7 Aromatic Rings: 1
Heavy Atoms: 11 QED Weighted: 0.696

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.099 MDCK Permeability: 0.00042403
Pgp-inhibitor: 0 Pgp-substrate: 0.031
Human Intestinal Absorption (HIA): 0.046 20% Bioavailability (F20%): 0.003
30% Bioavailability (F30%): 0.001

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.748 Plasma Protein Binding (PPB): 18.12%
Volume Distribution (VD): 3.851 Fu: 64.15%

ADMET: Metabolism

CYP1A2-inhibitor: 0.035 CYP1A2-substrate: 0.958
CYP2C19-inhibitor: 0.114 CYP2C19-substrate: 0.036
CYP2C9-inhibitor: 0.007 CYP2C9-substrate: 0.002
CYP2D6-inhibitor: 0.002 CYP2D6-substrate: 0.007
CYP3A4-inhibitor: 0.009 CYP3A4-substrate: 0.684

ADMET: Excretion

Clearance (CL): 8.05 Half-life (T1/2): 0.888

ADMET: Toxicity

hERG Blockers: 0.21 Human Hepatotoxicity (H-HT): 0.996
Drug-inuced Liver Injury (DILI): 0.94 AMES Toxicity: 0.17
Rat Oral Acute Toxicity: 0.479 Maximum Recommended Daily Dose: 0.536
Skin Sensitization: 0.93 Carcinogencity: 0.967
Eye Corrosion: 0.003 Eye Irritation: 0.607
Respiratory Toxicity: 0.957
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC000352 0.209 D0C0SK 0.262
ENC000113 0.171 D06HCP 0.224
ENC000477 0.167 D05GJW 0.221
ENC000112 0.159 D0R5RR 0.214
ENC001348 0.157 D03FLC 0.194
ENC000011 0.157 D0I0RJ 0.190
ENC001351 0.154 D0B8UJ 0.189
ENC002667 0.147 D0G8NN 0.186
ENC000577 0.146 D0A4IJ 0.184
ENC001225 0.140 D00NKB 0.183
*Note: the compound similarity was calculated by RDKIT.